ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO554

Hypoglycemia and Mortality Risk in Incident Hemodialysis Patients

Session Information

Category: Diabetic Kidney Disease

  • 602 Diabetic Kidney Disease: Clinical

Authors

  • Kang, Duk-Hee, Ewha University College of Medicine, Seoul, Korea (the Republic of)
  • Streja, Elani, Harold Simmons Center for Kidney Disease Research and Epidemiology, Orange, California, United States
  • You, Amy Seung, University of California, Irvine, Orange, California, United States
  • Lee, Yong kyu, University of California Irvine, Huntington Beach, California, United States
  • Kovesdy, Csaba P., University of Tennessee Health Science Center, Memphis, Tennessee, United States
  • Kalantar-Zadeh, Kamyar, University of California Irvine, School of Medicine, Orange, California, United States
  • Rhee, Connie, University of California Irvine, Huntington Beach, California, United States
Background

Hypoglycemia is a frequent occurrence in chronic kidney disease (CKD) patients due to alterations in glucose and insulin metabolism. Yet there are sparse data examining the predictors and clinical implications of hypoglycemia, including mortality risk, among incident hemodialysis patients.

Methods

Among 58,304 incident hemodialysis patients receiving care from a large national dialysis organization over the period 2007-2011, we first examined clinical characteristics associated with risk of hypoglycemia, defined as a blood glucose concentration of <70 mg/dL, in the first year of dialysis using expanded case-mix and laboratory-adjusted logistic regression models. We then examined the association between hypoglycemia during the first year of dialysis with all-cause mortality risk using expanded case-mix and laboratory adjusted Cox models.

Results

In the first year of dialysis, hypoglycemia was observed among 16.8% of diabetic and 6.9% of non-diabetic incident hemodialysis patients. In adjusted logistic regression models, clinical characteristics associated with higher risk of hypoglycemia included younger age, female sex, African-American race, presence of a central venous catheter, lower residual renal function, and longer dialysis session length. In the overall cohort, patients who experienced hypoglycemia had a higher risk of all-cause mortality (reference: absence of hypoglycemia): adjusted HR (95% CI) 1.08 (1.04, 1.13). In stratified analyses, hypoglycemia was also associated with higher mortality risk in the diabetic and non-diabetic subgroups: adjusted HRs (95% CIs) 1.08 (1.04-1.13) and 1.17 (0.94-1.45), respectively.

Conclusion

Hypoglycemia was a frequent occurrence among both diabetic and non-diabetic hemodialysis patients, and was associated with higher mortality risk. Further studies are needed to identify approaches that ameliorate risk of hypoglycemia in hemodialysis patients.

Funding

  • NIDDK Support